Empagliflozin Prescribing at PROSPECT SURGERY
Drugs used in diabetes | Endocrine System
Items (12m)
1,612
Total Quantity
37.5K
NHS Cost
£46.6K
vs National Avg
+157.6%
PROSPECT SURGERY prescribed 1,612 items of Empagliflozin over the last 12 months at a cost of £46,596 to the NHS. This is 157.6% above the national average prescribing rate. Empagliflozin is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
127
Jun 2026
115
Jun 2026
115
Jun 2026
120
Jun 2026
120
Jun 2026
125
Jun 2026
151
Jun 2026
127
Jun 2026
165
Jun 2026
152
Jun 2026
134
Jun 2026
161
Prescribing Details
| Total Items | 1,612 |
|---|---|
| Total Quantity | 37,484 |
| Total NHS Cost | £46,596 |
| Presentations | 2 different forms |
| vs National Average | +157.6% |
Empagliflozin Prescribing Comparison
| This practice | 1,612 items |
|---|---|
| National average per practice | 626 items |
| Difference | +157.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.